607. Melioidosis, emergent disease in Panama?
Session: Poster Abstract Session: Oh One World: Infections from Near and Far
Thursday, October 27, 2016
Room: Poster Hall
Posters
  • Poster Melioidosis final.pdf (2.1 MB)
  • Background: Melioidosis is a bacterial infection caused by Burkholderia pseudomallei, with less than a 100 cases identified as acquired in the Americas between 1947 and June 2015. Most of the cases in the world are reported from Southeast Asia and northern Australia.

    Methods: Retrospective review of medical record in Hospital Santo Tomas and Complejo Hospitalario Dr. Arnulfo Arias Madrid. These are the two main Hospitals in Panama city.

    Results: A total of seven cases were identified between 2009-2015. The diagnoses were made with positive blood cultures, being bacteremia the most common presentation with three of them with evidence of pneumonia and the other four with intra-abdominal abscesses with different localizations including the liver, spleen and pancreas. Other sites of infection were endocarditis, meningitis and septic arthritis documented in different patients. All of the patients had Diabetes mellitus as risk factor and came from rural areas of the Republic of Panama. Despite the treatment with carbapenems three of the patients died during hospitalization.

    Conclusion: Traditionally, Melioidosis has been recognized as an infectious disease endemic of Southeast Asia and northern Australia. Recent reports call for an increase awareness of this disease in the Americas, specially in the population of diabetic patients. More studies are needed to identify the specific areas of major risk in America, since the clinical picture is unspecific and requires microbiologic identification to be recognize.

    Ana Belen Arauz Rodriguez, MD1, Boris Castillo, MD2, Katiana Castillo, MD1 and Erika Santiago, Medical technichian3, (1)Hospital Santo Tomas, Panama, Panama, (2)Complejo Hospitalario Metropolitano Dr. Arnulfo Arias Madrid, Panama, Panama, (3)Hospital Santo Tomás, Panama, Panama

    Disclosures:

    A. B. Arauz Rodriguez, None

    B. Castillo, None

    K. Castillo, None

    E. Santiago, None

    Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.